Applera, Beckman Coulter Disclose Terms of Settlement for CE, PCR Suit; Licenses Will Cost Applera $35M and Beckman $20M | GenomeWeb

NEW YORK, April 27 (GenomeWeb News) - ABI parent Applera and Beckman Coulter are trying to settle an ongoing patent dispute, and each company has agreed to pay the other royalty-bearing licenses for their respective technologies.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.